Concepedia

Zdeněk Adam

ZA

Statistics

Publications

16

Citations

859

H-Index

15

Active since

2004

Affiliations

University Hospital Brno(Current)

Masaryk University

Charles University

University of Ostrava

Wilhelminen Hospital

Zdeněk Adam is an author at University Hospital Brno specializing in multiple myeloma, multiple myeloma treatment, and multiple myeloma therapy.

Publications per year

2004–2021

16

Publications

16

Thalidomide-dexamethasone compared with melphalan-prednisolone in elderly patients with multiple myeloma

Heinz Ludwig, Roman Hájek, Elena Tóthová et al. · Blood · 2008 · 206 citations · Full text

Medicine, Hematology, Oncology +13

Soft-tissue extramedullary multiple myeloma prognosis is significantly worse in comparison to bone-related extramedullary relapse

Luděk Pour, Henrieta Grešlíková, Renata Kupská et al. · Haematologica · 2013 · 183 citations · Full text

Medicine, Hematology, Oncology +14

Bendamustine-bortezomib-dexamethasone is an active and well-tolerated regimen in patients with relapsed or refractory multiple myeloma

Heinz Ludwig, H. Kasparu, Clemens Leitgeb et al. · Blood · 2013 · 103 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Gain of 1q21 Is an Unfavorable Genetic Prognostic Factor for Multiple Myeloma Patients Treated with High-Dose Chemotherapy

Pavel Němec, Zuzana Zemanová, Henrieta Grešlíková et al. · Biology of Blood and Marrow Transplantation · 2009 · 70 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Prognostic factors for survival after autologous transplantation: a single centre experience in 133 multiple myeloma patients

Marta Krejčí, Tomáš Büchler, Roman Hájek et al. · Bone Marrow Transplantation · 2004 · 50 citations

Medicine, Hematology, Oncology +15

1–5 of 16